excellent service and develop fixed-mobile-contents convergence (FMC) strategies to deliver a superior experience for our customers. The business sector recovered well in 2Q22 and benefited from the
Period As Of Details HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2022 Reviewed Company Q3 30/09/2022 HEALTH EMPIRE CORPORATION PUBLIC COMPANY LIMITED 2022 Reviewed Consolidated Q3 30/09/2022 HEALTH
economy demonstrated cautious growth driven by tourism-related sector expansion and subsided inflation, while facing political uncertainties and global economic risks. AIS core service revenue reported at
for kidney patients who receive replacement therapy with Hemodialysis by Hemodialysis machinery (Hemodialysis Center) and distribution of medical equipment as well as medical service concerning health
, growing the revenue by 21% YoY. Enterprise and other service revenue driven by digital transformation in the Thai business sector, especially for Cloud products and ICT solutions, increased 21% YoY. The
shrinking of the export sector due to lower demand from overseas trading partners. In addition, this has negatively impacted local economic activity, particularly consumption and investment in the private
Derivative Warrants | ALIHEA41C2601A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN JANUARY 2026
Derivative Warrants | ALIHEA41C2502A | DERIVATIVE CALL WARRANTS ON ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED (241) ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN FEBRUARY 2025